RKLB Stock Analysis: Rocket Lab USA | NASDAQ

Launch Services, Spacecraft Manufacturing, Orbital Rockets, Satellite Components

Total Rating 24

Safety 79

Buy Signal -0.90

Aerospace & Defense
Industry Rotation: -0.8

Market Cap: 33.6B
Avg Turnover: 1.14B

Risk 3d forecast

Volatility75.4%

VaR 5^th Pctl12.4%

VaR vs Median-0.29%

Reward TTM

Sharpe Ratio0.30

Rel. Str. IBD10

Rel. Str. Peer Group17.1 pctl

Character TTM

Beta3.457

Beta Downside2.522

Hurst Exponent0.586

Choppyness47.9%

Drawdowns 3y

Max DD66.16%

CAGR/Max DD1.96

CAGR/Mean DD6.28

EPS (Earnings per Share)

Last SUE: 0.47
Qual. Beats: 0

Revenue

Rev. CAGR: 54.62%
Rev. Trend: 99.6%

Last SUE: 0.79
Qual. Beats: 0

Warnings

Strong Share Dilution

High Debt/EBITDA With Thin Interest Coverage

High Debt While Negative Cash Flow

Interest Coverage Ratio Critical

Below Avwap Earnings

Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 5.8 years of data

Jan -3.0% 10

Feb -2.3% 10

Mar -10.6% 46

Apr +7.5% 13

May +21.6% 34

Jun +14.3% 13

Jul +14.2% 34

Aug -0.1% 9

Sep -12.0% 11

Oct +7.3% 43

Nov +7.0% 11

Dec +3.3% 10

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: RKLB Rocket Lab USA

Rocket Lab Corporation (NASDAQ: RKLB) is a U.S.-headquartered space company that operates across two segments: launch services and space systems. The company provides orbital launch services, spacecraft design and manufacturing, spacecraft components, optical systems, on-orbit management, and constellation management services, serving commercial, aerospace prime contractors, and government customers in the United States, Canada, Japan, and other international markets. The company is based in Long Beach, California, and was founded in 2006.

The launch services segment centers on the Electron, an operational small launch vehicle, and the Neutron, a medium-lift rocket currently in development intended for large constellation deployments, interplanetary missions, and potentially human spaceflight. The space systems segment supplies a range of components, subsystems, and integrated spacecraft solutions, reflecting a vertically integrated business model in which Rocket Lab manufactures key hardware in-house rather than relying solely on third-party suppliers.

The company is classified within the Industrials sector (Industrial Machinery & Supplies & Components sub-industry) and trades as a large-cap stock following its 2021 listing on the Nasdaq. The small and medium launch segment of the commercial space industry has seen growing demand driven by satellite constellation operators and government programs, though the sector remains capital-intensive and competitive.

Headlines to Watch Out For

Neutron rocket maiden flight unlocks medium-lift constellation revenue
Space Systems margin expansion drives path to space profitability
Competition from SpaceX pressures Electron launch pricing power

Piotroski VR-10 (Strict) 1.0

Net Income: -165.5m TTM > 0 and > 6% of Revenue
FCF/TA: -0.09 > 0.02 and ΔFCF/TA 4.27 > 1.0
NWC/Revenue: 307.8% < 20% (prev 124.9%; Δ 183.0% < -1%)
CFO/TA -0.05 > 3% & CFO -222.5m > Net Income -165.5m
Net Debt/EBITDA: error (EBITDA <= 0)
Current Ratio: 5.48 > 1.5 & < 3
Outstanding Shares: last quarter (629.7m) vs 12m ago 22.25% < -2%
Gross Margin: 37.26% > 18% (prev 29.04%; Δ 8.22% > 0.5%)
Asset Turnover: 26.80% > 50% (prev 32.47%; Δ -5.67% > 0%)
Interest Coverage Ratio: -24.71 > 6 (EBIT TTM -184.4m / Interest Expense TTM 7.46m)

Altman Z'' 7.69

A: 0.57 (Total Current Assets 2.90b - Total Current Liabilities 528.2m) / Total Assets 4.19b
B: -0.26 (Retained Earnings -1.11b / Total Assets 4.19b)
C: -0.06 (EBIT TTM -184.4m / Avg Total Assets 2.87b)
D: 5.02 (Book Value of Equity 3.49b / Total Liabilities 695.2m)
Altman-Z'' = 7.69 = AAA

Beneish M -2.53

DSRI: 1.14 (Receivables 235.9m/136.2m, Revenue 769.1m/504.3m)
GMI: 0.78 (GM 29.04% / 37.26%)
AQI: 1.35 (AQ_t 0.18 / AQ_t-1 0.14)
SGI: 1.53 (Revenue 769.1m / 504.3m)
TATA: 0.01 (NI -165.5m - CFO -222.5m) / TA 4.19b)
Beneish M = -2.53 (Cap -4..+1) = A

What is the price of RKLB shares?

As of November 02, 2026, the stock is trading at USD 54.73 with a total of 16,428,737 shares traded. Over the past week, the price has changed by +4.05%, over one month by -21.48%, over three months by -15.38% and over the past year by -10.16%.

Current recommended Stop Loss: 49.80 (which is 9% or 1.3 ATR below the current price).

Is RKLB a buy, sell or hold?

Rocket Lab USA has received a consensus analysts rating of 4.38. Therefore, it is recommended to buy RKLB.

StrongBuy: 12
Buy: 5
Hold: 4
Sell: 0
StrongSell: 0

What are the forecasts/targets for the RKLB price?

Analysts Target Price	102.2	86.6%

Rocket Lab USA (RKLB) - Fundamental Data Overview as of 27 October 2026

Market Cap USD = 33.6b (33.6b USD * 1.0 USD.USD)
P/E Forward = 1000.0
P/S = 43.7277
P/B = 11.3449
Revenue TTM = 769.1m USD
EBIT TTM = -184.4m USD
EBITDA TTM = -122.0m USD
Long Term Debt = 14.8m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 252.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 118.8m
Net Debt = -2.05b USD (calculated: Debt 252.5m - CCE 2.30b)
Enterprise Value = 31.6b USD (33.6b + Debt 252.5m - CCE 2.30b)
Interest Coverage Ratio = -24.71 (Ebit TTM -184.4m / Interest Expense TTM 7.46m)
EV/FCF = -85.10x (Enterprise Value 31.6b / FCF TTM -371.1m)
FCF Yield = -1.18% (FCF TTM -371.1m / Enterprise Value 31.6b)
FCF Margin = -48.25% (FCF TTM -371.1m / Revenue TTM 769.1m)
Net Margin = -21.51% (Net Income TTM -165.5m / Revenue TTM 769.1m)
Gross Margin = 37.26% ((Revenue TTM 769.1m - Cost of Revenue TTM 482.5m) / Revenue TTM)
Gross Margin QoQ = 36.13% (prev 38.18%)
Tobins Q-Ratio = 7.54 (Enterprise Value 31.6b / Total Assets 4.19b)
Interest Expense / Debt = 2.96% (Interest Expense 7.46m / Debt 252.5m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -145.7m (EBIT -184.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 5.48 (Total Current Assets 2.90b / Total Current Liabilities 528.2m)
Debt / Equity = 0.07 (Debt 252.5m / totalStockholderEquity, last quarter 3.49b)
Debt / EBITDA = 16.80 (negative EBITDA) (Net Debt -2.05b / EBITDA -122.0m)
Debt / FCF = 5.52 (negative FCF - burning cash) (Net Debt -2.05b / FCF TTM -371.1m)
Total Stockholder Equity = 2.19b (last 4 quarters mean from totalStockholderEquity)
RoA = -5.76% (Net Income -165.5m / Total Assets 4.19b)
RoE = -7.56% (Net Income TTM -165.5m / Total Stockholder Equity 2.19b)
RoCE = -8.37% (EBIT -184.4m / Capital Employed (Equity 2.19b + L.T.Debt 14.8m))
RoIC = -4.02% (negative operating profit) (NOPAT -145.7m / Invested Capital 3.62b)
WACC = 17.12% (E(33.6b)/V(33.9b) * Re(17.23%) + D(252.5m)/V(33.9b) * Rd(2.96%) * (1-Tc(0.21)))
Discount Rate = 17.23% (= CAPM, Blume Beta Adj.) -> capped to 12.54%
Shares (quarterly) Correlation: 91.13 | Cagr: 11.79%
[DCF] Fair Price = unknown (Cash Flow -371.1m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.47 | # QB: 0
Revenue Correlation: 99.58 | Revenue CAGR: 54.62% | SUE: 0.79 | # QB: 0
EPS current Quarter (2026-09-30): EPS=-0.07 | Chg30d=+1.19% | Revisions=-40% | Analysts=11
EPS current Year (2026-12-31): EPS=-0.27 | Chg30d=-0.33% | Revisions=+0% | GrowthEPS=+25.7% | GrowthRev=+59.4%
EPS next Year (2027-12-31): EPS=-0.09 | Chg30d=-4.47% | Revisions=+0% | GrowthEPS=+66.8% | GrowthRev=+38.2%
[Analyst] Revisions Ratio: -40% (up=0, down=2)